false 0001429560 0001429560 2024-11-26 2024-11-26 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): November 26, 2024

 

 

TREVENA, INC.

(Exact name of registrant as specified in its charter)

 

 

Delaware

(State or other jurisdiction of incorporation)

 

001-36193   26-1469215
(Commission
File No.)		     (IRS Employer
Identification No.)

 

 

955 Chesterbrook Boulevard, Suite 110

Chesterbrook, PA 19087

(Address of principal executive offices and zip code)

 

Registrant’s telephone number, including area code: (610) 354-8840

 

Not applicable

(Former name or former address, if changed since last report.)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
  
¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
  
¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
  
¨Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class  Trading Symbol(s)  Name of each exchange on which
 registered
Common Stock, $0.001 par value  TRVN  OTC Pink Open Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

 

Item 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

Departures and Appointments of Certain Officers

 

On November 26, 2024, the Board of Directors (the “Board”) of Trevena, Inc. (the “Company”) designated Katrine Sutton as the Company’s principal financial officer and principal accounting officer, effective November 26, 2024. As a result of this designation, Barry Shin will no longer serve as the Company’s principal financial officer or principal accounting officer, effective November 26, 2024. Mr. Shin’s replacement was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies, or practices.

 

Ms. Sutton, age 48, has served as the Company’s Vice President, Finance Planning and Analysis since July 2019. Prior to that, Ms. Sutton served as Vice President, Finance and Accounting with Synergy Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal therapies, from December 2015 to July 2019. Ms. Sutton holds a Bachelor of Science in Accounting from the University of Richmond and is a Certified Public Accountant.

 

There are no arrangements or understandings between Ms. Sutton and any other person pursuant to which Ms. Sutton was designated as principal financial officer and principal accounting officer. Ms. Sutton has no family relations with any directors or executive officers of the Company. There are no transactions to which the Company is a party and in which Ms. Sutton has a material interest that is required to be disclosed under Item 404(a) of Regulation S-K.

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    TREVENA, INC.
     
Date: November 27, 2024 By: /s/ Carrie Bourdow
    Carrie Bourdow
    Acting Chief Executive Officer and Principal Executive Officer

 

 

 

v3.24.3
Cover
Nov. 26, 2024
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Nov. 26, 2024
Entity File Number 001-36193
Entity Registrant Name TREVENA, INC.
Entity Central Index Key 0001429560
Entity Tax Identification Number 26-1469215
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 955 Chesterbrook Boulevard
Entity Address, Address Line Two Suite 110
Entity Address, City or Town Chesterbrook
Entity Address, State or Province PA
Entity Address, Postal Zip Code 19087
City Area Code 610
Local Phone Number 354-8840
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, $0.001 par value
Trading Symbol TRVN
Entity Emerging Growth Company false
Trevena (NASDAQ:TRVN)
Historical Stock Chart
From Nov 2024 to Dec 2024 Click Here for more Trevena Charts.
Trevena (NASDAQ:TRVN)
Historical Stock Chart
From Dec 2023 to Dec 2024 Click Here for more Trevena Charts.